Non-invasive tests in gastric diseases

Digestive and Liver Disease

Volumn 40, Issue 7, 2008, Pages 523-530

  di Mario, F ^a   Cavallaro, L G ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Gastric cancer; Gastritis; H. pylori; Serum pepsinogens

Indexed keywords

BIOLOGICAL MARKER; CAGA PROTEIN; CYTOKINE; GASTRIN 17; GHRELIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 8; PARIETAL CELL ANTIBODY; PEPSINOGEN I; PEPSINOGEN II;

ANTIBODY DETECTION; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; EARLY DIAGNOSIS; FALSE NEGATIVE RESULT; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTESTINE METAPLASIA; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; SHORT SURVEY; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; STOMACH PARIETAL CELL;

BIOLOGICAL MARKERS; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; GHRELIN; HUMANS; INTERLEUKIN-8; PEPSINOGENS; STOMACH DISEASES; STOMACH NEOPLASMS;

EID: 44949220043     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.028     Document Type: Short Survey

References (56)

1. Lambert R. Diagnosis of esophagogastric tumors. Endoscopy 36 (2004) 110-119
2. Becker K.F., Keller G., and Hoefler H. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 9 (2000) 5-11
3. Linch H.T., Grady W., Suriano G., and Huntsman D. Gastric cancer: new genetic development. Surg Oncol 90 (2005) 114-133
4. Genta R.M. The gastritis connection. Prevention and early detection of gastric neoplasms. J Clin Gastroenterol 36 (2003) S44-S49
5. Correa P. A new paradigm for human carcinogenesis. J Clin Gastroenterol 30 (2000) 341-342
6. Samloff I.M., Varis K., Ihamaki T., Siurala M., and Trotter J.I. Relationship among serum pepsinogen I, serum pepsinogen II and serum gastric mucosa histology. Gastroenterology 83 (1982) 204-209
7. Samloff I.M., Secrist D.M., and Passaro Jr. E. A study of the relationship between serum group I pepsinogen and gastric acid secretion. Gastroenterology 69 (1975) 1198-2000
8. Samloff I.M., Liebman W.M., and Panitch N.M. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 69 (1975) 83-90
9. Rotter J.I., Sones J.Q., Samloff I.M., Richardson C.T., Gursky J.M., Walsh J.H., et al. Duodenal ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal disorder. N Engl J Med 300 (1979) 63-66
10. Battaglia G., Farini R., Di Mario F., Piccoli A., Plebani M., Vianello F., et al. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. Am J Gastroenterol 79 (1984) 831-834
11. Marshall B.J., Goodwin C.S., Warren J.R., Murray R., Blincow E.D., Blackbourn S.J., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2 (1988) 1437-1442
12. Kuipers E.J., Uyterlinde A.M., Peña A.S., Roosendaal R., Pals G., Nelis G.F., et al. Long term sequelae of Helicobacter pylori gastritis. Lancet 55 (1995) 2111-2115
13. Mertz H.R., Peterson W.L., and Walsh J.H. "Familial hyperpesinogenemia" and Helicobacter pylori infection. Am J Gastroenterol 95 (2000) 943-946
14. Samloff I.M., and Liebman W.M. Cellular localization of the group II in human stomach and duodenum by immunofluorescence. Gastroenterology 65 (1973) 36-42
15. Mukoubayashi C., Yanaoka K., Ohata H., Arii K., Tamai H., Oka M., et al. Serum pepsinogen and gastric cancer screening. Intern Med 46 (2007) 261-266
16. Asaka M., Kimura T., Kudo M., Takeda H., Mitani S., Miyazaki T., et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102 (1992) 760-766
17. Wagner S., Haruma K., Gladziwa U., Soudah B., Gebel M., Bleck J., et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gasteroenterol 89 (1994) 1211-1218
18. Plebani M., Basso D., Cassaro M., Brigato L., Scrigner M., Toma A., et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gasteroenterol 91 (1996) 954-957
19. Bodger K., Wyatt J.I., and Heatley R.V. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 6 (2001) 216-223
20. Di Mario F., Cavallaro L.G., Moussa A.M., Caruana P., Merli R., Maini A., et al. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci 51 (2006) 1791-1795
21. Di Mario F., Moussa A.M., Cavallaro L.G., Caruana P., Merli R., Bertolini S., et al. Clinical usefulness of serum pepsinogens II in the management of Helicobacter pylori infection. Digestion 70 (2004) 167-172
22. Vaananen H., Vauhkonen M., Helske T., Kaariainen I., Rasmussen M., Tunturi-Hihnala H., et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 15 (2003) 885-891
23. Plebani M., Di Mario F., Vianello F., Giordano A., Masiero M., Lazzaretto M., et al. Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients. Clin Biochem 16 (1983) 20-22
24. Derakhshan M.H., El-Omar E., Oien K., Gillen D., Fyfe V., Crabtree J.E., et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 59 (2006) 1293-1299
25. Suzuki H., Masaoka T., Hosoda H., Nomura S., Ohara T., Kangawa K., et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and serum pepsinogen I/II ratio-a possible novel non-invasive marker for gastric atrophy. Hepatogastroenterology 51 (2004) 1249-1254
26. Sipponen P., Ranta P., Helske T., Kaarianen I., Maki T., and Linnala A. Serum levels of amigdated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 37 (2002) 785-791
27. Vakil R., Rhew D., and Soll A. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori. Am J Gastroenterol 95 (2000) 1691-1698
28. Germanà B., Di Mario F., Cavallaro L.G., Moussa A.M., Lecis P., Liatopoulou S., et al. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 37 (2005) 501-508
29. Kokkola A., Rautelin H., Puolakkainen P., Sipponen P., Farkkila M., Haapiainen R., et al. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J Clin Microbiol 36 (1998) 1808-1810
30. Rugge M., Meggio M., Pennelli G., Piscioli F., Giacomelli L., De Pretis G., et al. Gastritis staging in clinical practice: the olga staging system. Gut 56 (2007) 631-636
31. Sasazuki S., Inoue M., Iwasaki M., Otani T., Yamamoto S., Ikeda S., et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev 15 (2006) 1341-1347
32. Kuipers E.J., Perez-Perez G.I., Meuwissen S.G., and Blaser M.J. Helicobacter pylori and atrophic gastritis: importance of the CagA status. J Natl Cancer Inst 55 (1995) 2111-2115
33. Klaamas K., Held M., Wadstrom T., Lipping A., and Kurtenov O. IgG immuno response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 67 (1996) 1-5
34. El Omar E.M., Carrington M., Chow W.H., McColl K.E., Young H.A., Herrera J., et al. Interleukin-1 polymorphism associated with increased risk of gastric cancer. Nature 404 (2001) 398-402
35. Sanduleanu S., Bruine D.E., Biemond I., Stridsberg M., Jonkers D., Lundqvist G., et al. Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. Eur J Clin Invest 33 (2003) 147-154
36. Karlsson F.A., Burnam P., Loof L., and Mardh S. The major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+, K+ adenosine triphosphatase of the stomach. J Clin Invest 81 (1990) 475-479
37. Betterle C., Mazzi P.A., Pedini B., Accordi F., Cecchetto A., and Presotto F. Complement fixing gastric parietal-cell autoantibodies. A good marker for the identification of type A chronic atrophic gastritis. Autoimmunity 1 (1988) 267-274
38. Negrini R., Savio A., Poiesi C., Appelmelk B.J., Buffoli F., Paterlini A., et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111 (1996) 655-665
39. Presotto F., Sabini B., Cecchetto A., Plebani M., De Lazzari F., Pedini B., et al. Helicobacter pylori and gastric autoimmune diseases: is there a link?. Helicobacter 8 (2003) 578-579
40. Ito M., Haruma K., Kaya S., Kamada T., Kim S., Sasaki A., et al. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis. Scand J Gastroenterol 37 (2002) 287-293
41. Naito Y., Ito M., Watanabe T., and Suzuki H. Biomarkers in patients with gastric inflammation: a systematic review. Digestion 72 (2005) 164-180
42. Varis K., Sipponen P., Laxén F., Samloff I.M., Huttunen J.K., Taylor P.R., et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol 35 (2000) 950-956
43. Watabe H., Mitsushima T., Yamaji Y., Okamoto M., Wada R., Kokubo T., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54 (2005) 764-768
44. Oishi Y., Kiyohara Y., Kubo M., Tanaka K., Tanizaki Y., Ninomiya T., et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 163 (2006) 629-637
45. Miki K., Morita M., Sasajima M., Hoshima R., Kanda E., and Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98 (2003) 735-739
46. Taguchi A., Ohmiya N., Itoh A., Hirooka Y., Niwa Y., Mori N., et al. Severity of atrophic gastritis related to antiparietal cells and gastric carcinogenesis, including p53 mutations. J Gastroenterol Hepatol 21 (2006) 545-551
47. Palli D., Masala G., Del Giudice G., Plebani M., Basso D., Berti D., et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 120 (2007) 859-867
48. Ley C., Mohar L., Guarner J., Herrera-Goepfert R., Figueroa L.S., Halperin D., et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev 10 (2001) 107-112
49. Rollan A., Ferreccio C., Gederlini A., Serrano C., Torres J., and Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 28 (2006) 7172-7178
50. Sierra R., Une C., Ramirez V., Gonzalez Ma.I., Ramirez J.A., de Mascarel A., et al. Association of serum pepsinogen with atrophic body gastritis in Costa Rica. Clin Exp Med 6 (2006) 72-78
51. Broutet N., Plebani M., Sakarovitch C., Sipponen P., Megraud F., and The Europygast Study Group. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 88 (2003) 1239-1247
52. Ricci C., Vakil N., Rugge M., Gatta L., Perna F., Osborn J.F., et al. Serological markers for gastric atrophy in asymptomatic patients with Helicobacter pylori. Am J Gastreoenterol 99 (2004) 1910-1915
53. Nardone G., Rocco A., Staibano S., Mezza E., Autiero E., Compare D., et al. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Ther Pharmacol 22 (2005) 1139-1146
54. Graham D.Y., Nurgalieva Z.Z., El Zimaity H.M.T., Operkun A.R., Campos A., Guerrero L., et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 4 (2006) 306-314
55. Dinis-Ribeiro M., Yamaki G., Miki K., Costa-Pereira A., Matsukawa M., and Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 11 (2004) 141-147
56. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 9 (2006) 245-253